載入...
Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes
Peroxisome proliferator-activated receptor gamma (PPARG) is a master transcriptional regulator of adipocyte differentiation and a canonical target of antidiabetic thiazolidinedione medications. In rare families, loss-of-function (LOF) mutations in PPARG are known to cosegregate with lipodystrophy an...
Na minha lista:
| 發表在: | Proc Natl Acad Sci U S A |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
National Academy of Sciences
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4246964/ https://ncbi.nlm.nih.gov/pubmed/25157153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1410428111 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|